Wissel J - Search Results

1

Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus.

Bensmail D, Wissel J, Laffont I, Simon O, Scheschonka A, Flatau-Baqué B, Dressler D, Simpson DM. Bensmail D, et al. Among authors: wissel j. Ann Phys Rehabil Med. 2021 Mar;64(2):101376. doi: 10.1016/j.rehab.2020.03.005. Epub 2020 Apr 12. Ann Phys Rehabil Med. 2021. PMID: 32294561 Free article. Clinical Trial.

2

[Botulinum toxin type A treatment of upper limb spasticity].

Wissel M, Wissel J. Wissel M, et al. Among authors: wissel j. Wien Klin Wochenschr. 2001;113 Suppl 4:16-9. Wien Klin Wochenschr. 2001. PMID: 15506047 Review. German.

3

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T. Wissel J, et al. Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Wien Klin Wochenschr. 2001. PMID: 15506048 Review. German.

4

European consensus table on the use of botulinum toxin type A in adult spasticity.

Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, Duarte E, Geurts AC, Gracies JM, Haboubi NH, Juan FJ, Kasch H, Kätterer C, Kirazli Y, Manganotti P, Parman Y, Paternostro-Sluga T, Petropoulou K, Prempeh R, Rousseaux M, Slawek J, Tieranta N. Wissel J, et al. J Rehabil Med. 2009 Jan;41(1):13-25. doi: 10.2340/16501977-0303. J Rehabil Med. 2009. PMID: 19197564 Free article.

5

Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.

Borg J, Ward AB, Wissel J, Kulkarni J, Sakel M, Ertzgaard P, Åkerlund P, Reuter I, Herrmann C, Satkunam L, Wein T, Girod I, Wright N; BEST Study Group. Borg J, et al. Among authors: wissel j. J Rehabil Med. 2011 Jan;43(1):15-22. doi: 10.2340/16501977-0663. J Rehabil Med. 2011. PMID: 21174051 Free article. Clinical Trial.

6

Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?

Hefter H, Jost WH, Reissig A, Zakine B, Bakheit AM, Wissel J. Hefter H, et al. Among authors: wissel j. Int J Rehabil Res. 2012 Sep;35(3):227-33. doi: 10.1097/MRR.0b013e328353e3d4. Int J Rehabil Res. 2012. PMID: 22555318

7

Toward an epidemiology of poststroke spasticity.

Wissel J, Manack A, Brainin M. Wissel J, et al. Neurology. 2013 Jan 15;80(3 Suppl 2):S13-9. doi: 10.1212/WNL.0b013e3182762448. Neurology. 2013. PMID: 23319481 Review.

8

Impact of physical exercise on reaction time in patients with Parkinson's disease-data from the Berlin BIG Study.

Ebersbach G, Ebersbach A, Gandor F, Wegner B, Wissel J, Kupsch A. Ebersbach G, et al. Among authors: wissel j. Arch Phys Med Rehabil. 2014 May;95(5):996-9. doi: 10.1016/j.apmr.2013.10.020. Epub 2013 Nov 11. Arch Phys Med Rehabil. 2014. PMID: 24231400 Clinical Trial.

9

Functional goal achievement in post-stroke spasticity patients: the BOTOX® Economic Spasticity Trial (BEST).

Ward AB, Wissel J, Borg J, Ertzgaard P, Herrmann C, Kulkarni J, Lindgren K, Reuter I, Sakel M, Säterö P, Sharma S, Wein T, Wright N, Fulford-Smith A; BEST Study Group. Ward AB, et al. Among authors: wissel j. J Rehabil Med. 2014 Jun;46(6):504-13. doi: 10.2340/16501977-1817. J Rehabil Med. 2014. PMID: 24715249 Free article. Clinical Trial.

10

Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study.

Fietzek UM, Kossmehl P, Schelosky L, Ebersbach G, Wissel J. Fietzek UM, et al. Among authors: wissel j. Eur J Neurol. 2014 Aug;21(8):1089-1095. doi: 10.1111/ene.12381. Epub 2014 Feb 12. Eur J Neurol. 2014. PMID: 24754350 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page